Newcardio Stock Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and NewCardio are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days NewCardio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, NewCardio is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Total Cashflows From Investing Activities | -67.6 K |
NewCardio |
NewCardio Relative Risk vs. Return Landscape
If you would invest 0.00 in NewCardio on September 4, 2024 and sell it today you would earn a total of 0.00 from holding NewCardio or generate 0.0% return on investment over 90 days. NewCardio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than NewCardio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NewCardio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NewCardio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NewCardio, and traders can use it to determine the average amount a NewCardio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NWCI |
Based on monthly moving average NewCardio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewCardio by adding NewCardio to a well-diversified portfolio.
NewCardio Fundamentals Growth
NewCardio Stock prices reflect investors' perceptions of the future prospects and financial health of NewCardio, and NewCardio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NewCardio Stock performance.
| Return On Asset | -2.24 | ||||
| Operating Margin | (157.65) % | ||||
| Current Valuation | 49.72 K | ||||
| Shares Outstanding | 33.15 M | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 257.4 K | ||||
| Gross Profit | 105.1 K | ||||
| EBITDA | (7.26 M) | ||||
| Net Income | (11.5 M) | ||||
| Cash And Equivalents | 13.06 K | ||||
| Total Debt | 6.01 M | ||||
| Current Ratio | 0.01 X | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (4.56 M) | ||||
| Market Capitalization | 49.72 K | ||||
| Total Asset | 2.85 M | ||||
| Working Capital | (5.38 M) | ||||
| Current Asset | 35 K | ||||
| Current Liabilities | 5.41 M | ||||
About NewCardio Performance
By evaluating NewCardio's fundamental ratios, stakeholders can gain valuable insights into NewCardio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NewCardio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NewCardio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.73) | (4.96) | |
| Return On Capital Employed | 11.10 | 11.66 | |
| Return On Assets | (4.63) | (4.87) | |
| Return On Equity | 4.18 | 2.57 |
Things to note about NewCardio performance evaluation
Checking the ongoing alerts about NewCardio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NewCardio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NewCardio generated a negative expected return over the last 90 days | |
| NewCardio has some characteristics of a very speculative penny stock | |
| NewCardio currently holds 6.01 M in liabilities. NewCardio has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about NewCardio's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 257.4 K. Net Loss for the year was (11.5 M) with profit before overhead, payroll, taxes, and interest of 105.1 K. | |
| NewCardio currently holds about 13.06 K in cash with (4.56 M) of positive cash flow from operations. | |
| NewCardio has a frail financial position based on the latest SEC disclosures |
- Analyzing NewCardio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NewCardio's stock is overvalued or undervalued compared to its peers.
- Examining NewCardio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NewCardio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NewCardio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NewCardio's stock. These opinions can provide insight into NewCardio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NewCardio Stock analysis
When running NewCardio's price analysis, check to measure NewCardio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewCardio is operating at the current time. Most of NewCardio's value examination focuses on studying past and present price action to predict the probability of NewCardio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewCardio's price. Additionally, you may evaluate how the addition of NewCardio to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |